Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | AMGN | VRTX | GILD | BMY |
| Company | Verona Pharma Plc ADR | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 39.22 | 272.96 | 462.33 | 91.66 | 56.38 |
| High | 41.64 | 274.07 | 466.71 | 92.11 | 56.38 |
| Low | 39.15 | 270.02 | 459.79 | 89.15 | 55.04 |
| Last | 41.42 | 270.62 | 463.73 | 91.86 | 55.78 |
| Change | +2.16 | -3.44 | -0.39 | -0.52 | -0.50 |
| % Change | +5.50% | -1.26% | -0.08% | -0.57% | -0.89% |
| Volume | 1,218,500 | 2,906,400 | 1,097,100 | 7,515,400 | 9,406,100 |
| 20-Day Average Volume | 1,017,560 | 4,613,980 | 1,324,615 | 6,910,210 | 9,738,295 |
| Previous Close | 39.26 | 274.06 | 464.12 | 92.38 | 56.28 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 39.08 | 280.23 | 462.14 | 91.16 | 58.15 |
| 20-Day Raw Stochastic | 96.91% | 32.44% | 53.61% | 67.39% | 13.12% |
| 20-Day Relative Strength | 63.44% | 32.82% | 47.23% | 54.11% | 47.29% |
| Weighted Alpha | +148.15 | -9.51 | +9.84 | +23.55 | +15.85 |
| Today's Opinion | 100% Buy | 88% Sell | 24% Sell | 100% Buy | 80% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 24% Sell | 100% Buy | 80% Buy |
| Last Month's Opinion | 100% Buy | 40% Sell | 88% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.27% since 12/06/24 | -0.72% since 12/06/24 | +0.35% since 12/06/24 | -0.30% since 12/06/24 | -6.06% since 12/06/24 |
| Low | 38.77 on 12/12/24 | 270.02 on 12/13/24 | 459.79 on 12/13/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 |
| High | 41.64 on 12/13/24 | 280.00 on 12/09/24 | 476.46 on 12/10/24 | 94.65 on 12/11/24 | 59.76 on 12/09/24 |
| 1-Month | |||||
| %Chg | +12.16% since 11/13/24 | -10.22% since 11/13/24 | -6.24% since 11/13/24 | -0.84% since 11/13/24 | -4.50% since 11/13/24 |
| Low | 34.51 on 11/18/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 | 55.04 on 12/13/24 |
| High | 41.64 on 12/13/24 | 298.48 on 11/14/24 | 496.33 on 11/14/24 | 94.65 on 12/11/24 | 60.68 on 11/25/24 |
| 3-Month | |||||
| %Chg | +39.09% since 09/13/24 | -18.60% since 09/13/24 | -4.46% since 09/13/24 | +10.92% since 09/13/24 | +13.54% since 09/13/24 |
| Low | 27.54 on 09/27/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 81.83 on 09/26/24 | 48.78 on 09/18/24 |
| High | 41.64 on 12/13/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | +166.20% since 06/13/24 | -9.34% since 06/13/24 | -3.19% since 06/13/24 | +44.52% since 06/13/24 | +34.47% since 06/13/24 |
| Low | 14.14 on 06/28/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 62.69 on 06/18/24 | 39.35 on 07/05/24 |
| High | 41.64 on 12/13/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,331,825 | 145,467,184 | 119,423,920 | 114,475,768 | 113,131,712 |
| Shares Outstanding, K | 80,440 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -54,370,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 5,620,000 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -42,960,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 0.46 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.56 on 11/04/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/04/24 | 02/04/25 | 02/03/25 | 02/04/25 | 02/06/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 12/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | 12/13/24 | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.26 | 0.00 | 20.85 | 48.10 |